Connect with us
[ad_1] Updated Dec 27, 2023, 7:34 am EST / Original Dec 27, 2023, 4:26 am EST Stock futures traded slightly lower Wednesday after the S&P 500 finished...
[ad_1] Bristol Myers Squibb will acquire radiopharmaceutical therapeutics company RayzeBio for $62.50 a share in cash. Continue reading this article with a Barron’s subscription. View Options...
[ad_1] Two weeks ago, bluebird bio secured Food and Drug Administration approval for its gene therapy for sickle cell disease, a significant milestone for the roughly...
[ad_1] Dec 19, 2023, 4:31 am EST Stock futures traded flat Tuesday, a day after the S&P 500 finished up 0.5% and moved closer to its...
[ad_1] Stock futures pointed higher Friday as Wall Street returned for a shortened trading session following the Thanksgiving holiday. Retailers will be in focus on Black...
[ad_1] These Stocks Are Moving the Most Today: Plug Power, Trade Desk, Doximity, Unity Software, Illumina, Wynn, and More [ad_2] Source link
[ad_1] Ardelyx Inc. ARDX, -0.58% on Tuesday won its long fight for U.S. regulatory approval of a treatment designed to help patients with chronic kidney disease....
[ad_1] Updated Oct. 17, 2023 2:47 am ET Lonza Group warned that its profitability will take a hit next year from losing revenue from an agreement...
[ad_1] This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/stock-market-movers-8c0c7b23 Updated...
[ad_1] The Food and Drug Administration late Friday approved the first-ever pill that can be taken at home for postpartum depression. The medication, called zuranolone, and...
[ad_1] This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/solaredge-stock-guidanceprice-solar-e54cc9fb Updated...
[ad_1] Pfizer Stock Gains After Earnings Beat. Revenue and Outlook Aren’t So Good. [ad_2] Source link
[ad_1] This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/stock-market-movers-fb3791aa Updated...
[ad_1] Illumina CEO Francis deSouza Resigns Amid Regulatory Hurdles, Proxy Fight [ad_2] Source link
[ad_1] By Anthony O. Goriainoff AstraZeneca said Thursday that its and MSD’s Lynparza cancer treatment had been approved in the U.S. for the treatment of metastatic...
[ad_1] This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/first-solar-stock-buying-solar-tech-firm-evolar-da85f0b1 Updated...
[ad_1] Pfizer Agrees to Buy Seagen for $43 Billion [ad_2] Source link
[ad_1] Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t...